Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report - Amgen (NASDAQ:AMGN), AstraZeneca (NYSE:AZN)
Published on March 16, 2026.
Amgen (AMGN), AstraZeneca (ISN), and GSK are set to offer deep prescription drug discounts on their platforms, with Amgen offering an 80% discount on Amjevita, a drug used for rheumatoid arthritis, psoriasis, and ulcerative colitis. GSK will offer a 55% discount to Incruse, a medication for COPD at $159. Despite pressure from President Trump and potential tariff threats, these companies have agreed to most-favoured-nation pricing (MFN). The website, TrumpRx, does not sell medicines directly but allows consumers to search for discounted prices and redeem them through manufacturers' websites.
Related Articles
Gen Z Says Hitting This Age Officially Makes You Old
A poll reveals Gen Z believes old age officially starts at 62, expressing pessimistic attitudes and pessimistic outlooks about their future, reflecting broader societal attitudes than traditional attitudes.
TSA wait times could hit 2 hours at Armstrong International amid partial government shutdown
TSA wait times at Armstrong International Airport could rise to up to two hours due to a partial government shutdown, with many agents working without pay.
SaverOne Announces European Patent Office Grants European Patent For A System Method and Unit To Scan Communication Channels In Enclosed Spaces - Saverone 2014 (NASDAQ:SVRE)
The European Patent Office granted Saverometer-style approval for Southeastern, allowing for a temporary closure of the year-long holiday season, with Southeastern European Union (EU) officials overseeing.